SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-22-001635
Filing Date
2022-02-14
Accepted
2022-02-14 16:13:36
Documents
1
Period of Report
2021-02-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 3471
  Complete submission text file 0001654954-22-001635.txt   5117
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 157 TECHNOLOGY DRIVE IRVINE CA 92618
Business Address
SHROTRIYA RAJESH C MD (Reporting) CIK: 0001193918 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40023 | Film No.: 22632023